CN Stock MarketDetailed Quotes

603087 Gan & Lee Pharmaceuticals.

Watchlist
  • 45.77
  • +0.24+0.53%
Market Closed Dec 20 15:00 CST
27.51BMarket Cap47.38P/E (TTM)

Gan & Lee Pharmaceuticals. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
67.20%3.5B
0.45%3.08B
-6.96%2.55B
-15.49%2.44B
-29.29%2.09B
-6.41%3.06B
-19.08%2.74B
-12.57%2.89B
-4.51%2.96B
8.62%3.27B
Transactional financial assets
-24.59%1.57B
16.85%1.79B
42.36%2.35B
47.34%2.41B
14.33%2.08B
4.64%1.53B
5.93%1.65B
0.72%1.64B
51.03%1.82B
33.50%1.47B
Notes receivable and accounts receivable
-34.48%260.95M
33.94%371.01M
30.78%269.6M
117.72%383.74M
210.63%398.29M
1.61%277M
-72.23%206.15M
-81.13%176.25M
-80.95%128.22M
-59.54%272.62M
-Accounts receivable
-34.48%260.95M
33.94%371.01M
30.78%269.6M
117.72%383.74M
210.63%398.29M
1.61%277M
-72.23%206.15M
-81.13%176.25M
-80.95%128.22M
-59.54%272.62M
Other receivables (including interest and dividends)
5.40%4.07M
-29.47%14.86M
-10.44%3.6M
-40.70%3.49M
-22.03%3.86M
-63.58%21.07M
-44.45%4.02M
-9.23%5.89M
-38.25%4.95M
942.25%57.84M
-Dividend receivable
----
-40.19%10.38M
----
----
----
-67.29%17.36M
----
----
----
--53.08M
-Other receivable
----
20.80%4.47M
----
----
----
-22.22%3.7M
----
-9.23%5.89M
----
-14.19%4.76M
Advance payment
79.14%65.04M
81.73%77.37M
20.62%59.37M
-10.87%40.98M
-24.39%36.31M
-13.40%42.58M
-13.09%49.22M
-25.98%45.98M
-50.02%48.02M
-27.42%49.16M
Inventories
19.72%1.03B
26.80%950.34M
35.34%932.04M
32.66%860.51M
28.53%858.85M
2.28%749.46M
-5.96%688.68M
-0.41%648.65M
16.10%668.23M
26.75%732.72M
Receivable financing
-41.68%10.44M
-44.74%6.31M
-37.02%18.56M
-87.72%1.63M
542.30%17.9M
121.51%11.42M
3,040.73%29.47M
1,474.78%13.32M
-93.89%2.79M
-63.70%5.16M
Non-current assets due within one year
----
----
----
----
----
----
-27.84%201.33M
-27.16%201.36M
-26.47%201.34M
90.91%312.8M
Other current assets
2,591.34%52.86M
189.96%41.69M
-39.83%31.88M
-30.59%32.26M
-77.45%1.96M
-35.66%14.38M
484.55%52.99M
388.57%46.48M
-97.77%8.71M
-94.27%22.35M
Total current assets
18.23%6.49B
10.82%6.33B
10.50%6.22B
9.03%6.18B
-6.03%5.49B
-7.73%5.71B
-16.98%5.62B
-17.56%5.66B
-8.26%5.84B
3.12%6.19B
Non Current assets
Debt investment
63.25%493.28M
--409.66M
--307.12M
--304.66M
--302.17M
----
----
----
----
----
Other non-current financial assets
0.00%30M
0.00%30M
0.00%30M
0.00%30M
0.00%30M
0.00%30M
0.00%30M
0.00%30M
--30M
--30M
Fixed assets
----
29.80%2.34B
----
----
----
9.53%1.8B
----
-3.39%1.65B
----
-2.48%1.65B
Constru in process
----
-19.96%1.51B
----
----
----
64.02%1.89B
----
129.25%2B
----
44.41%1.15B
Construction materials
----
-1.73%2.28M
----
----
----
-0.53%2.32M
----
-0.30%2.33M
----
-0.50%2.33M
Intangible assets
-2.60%273.22M
-2.82%275.36M
-5.27%271.28M
-5.25%278.08M
-4.42%280.51M
-1.61%283.35M
-1.13%286.38M
-0.85%293.48M
10.32%293.47M
16.09%287.99M
Development expenditure
4.56%831.88M
4.39%823.38M
7.26%818.63M
10.99%813.11M
12.19%795.57M
21.06%788.78M
22.36%763.2M
27.07%732.56M
33.00%709.16M
20.04%651.58M
Long deferred expense
-19.02%7.54M
-18.15%7.98M
-17.30%8.43M
-16.60%8.87M
-15.94%9.31M
-15.23%9.76M
-14.65%10.19M
-14.10%10.63M
-10.86%11.08M
-10.19%11.51M
Deferred tax assets
50.81%165.06M
37.50%157.01M
17.25%152.24M
22.21%168.95M
94.40%109.45M
177.11%114.19M
237.57%129.84M
348.83%138.25M
113.99%56.3M
52.03%41.21M
Usufruct assets
-50.10%4.57M
-54.17%4.56M
-58.73%4.48M
-45.43%6.59M
-31.23%9.16M
-29.76%9.95M
-27.81%10.84M
-25.28%12.08M
4.58%13.32M
4.01%14.17M
Other non current assets
-39.16%56.6M
-33.18%54.2M
-55.34%37M
-34.67%49.99M
-77.30%93.03M
-79.02%81.12M
-73.21%82.84M
-68.16%76.51M
49.75%409.8M
98.16%386.6M
Total non current assets
7.43%5.73B
12.07%5.62B
10.73%5.5B
12.07%5.54B
17.03%5.34B
18.68%5.02B
20.01%4.97B
24.11%4.94B
17.21%4.56B
10.14%4.23B
Total assets
12.90%12.22B
11.40%11.95B
10.61%11.72B
10.45%11.72B
4.08%10.83B
2.99%10.73B
-2.94%10.6B
-2.27%10.61B
1.40%10.4B
5.86%10.42B
Liabilities
Current liabilities
Notes payable and accounts payable
23.73%111.04M
-1.57%96.32M
24.20%107.43M
136.15%105.54M
54.32%89.74M
94.58%97.86M
155.94%86.5M
18.42%44.69M
91.62%58.16M
48.33%50.29M
-Accounts payable
23.73%111.04M
-1.57%96.32M
24.20%107.43M
136.15%105.54M
54.32%89.74M
94.58%97.86M
155.94%86.5M
18.42%44.69M
91.62%58.16M
48.33%50.29M
Contract liabilities
9.79%52.26M
-47.03%30.87M
-40.91%32.64M
-22.21%52.99M
-58.20%47.6M
30.19%58.27M
74.70%55.24M
86.32%68.13M
115.49%113.87M
-21.94%44.76M
Advance receipts
----
----
----
----
----
----
--251.99K
--603.56K
--1.1M
----
Salaries payable
17.91%167.51M
-17.79%127.51M
-1.78%151.94M
-1.59%139.76M
-10.14%142.07M
37.41%155.1M
10.61%154.69M
4.51%142.02M
26.72%158.11M
-8.70%112.87M
Taxs payable
-14.88%18.81M
-5.57%14.66M
-19.31%10.21M
17.33%16.91M
62.02%22.1M
-12.94%15.53M
-79.24%12.65M
-88.89%14.41M
-63.47%13.64M
-61.97%17.83M
Other payable (including interest and dividends)
13.34%454.18M
11.81%491.61M
-11.18%377.54M
-15.09%454.01M
92.96%400.71M
195.59%439.67M
201.19%425.06M
288.63%534.68M
-8.77%207.66M
-49.60%148.74M
-Dividend payable
--1.97M
--18.83M
----
----
----
----
----
----
----
----
-Other payable
----
7.53%472.78M
----
----
----
195.59%439.67M
----
288.63%534.68M
----
-33.13%148.74M
Non current liabilities due within one year
-84.54%2.36M
-81.71%2.37M
-74.42%2.29M
-47.66%3.96M
111.73%15.28M
77.58%12.96M
36.24%8.96M
-4.91%7.56M
97.25%7.21M
71.63%7.3M
Other current liabilities
227.01%517.84K
59.33%368.71K
-17.55%297.87K
-70.56%275.58K
-74.01%158.36K
37.90%231.41K
149.90%361.26K
713.09%936.18K
87.63%609.35K
-70.75%167.81K
Total current liabilities
12.40%806.67M
-2.04%763.71M
-8.25%682.35M
-4.87%773.45M
28.07%717.66M
104.10%779.61M
79.62%743.71M
67.45%813.04M
17.50%560.36M
-32.00%381.97M
Current liabilities
Long term account payable
----
21.19%13.65M
----
----
----
4.91%11.27M
----
20.34%12.27M
----
652.77%10.74M
Deferred tax liabilities
91.01%21.86M
--19.3M
----
----
-34.97%11.45M
----
----
----
-53.77%17.6M
-8.24%31.11M
Long term deferred income
-6.33%171.13M
-5.41%175.02M
-5.37%177.32M
-4.27%179.63M
-3.63%182.7M
11.97%185.04M
11.99%187.38M
32.16%187.63M
32.15%189.58M
13.53%165.25M
Lease liabilities
-55.10%3.67M
-55.64%3.78M
-51.54%3.91M
-34.58%5.45M
-39.06%8.18M
-35.64%8.53M
-38.16%8.07M
-31.55%8.33M
-2.45%13.42M
-8.93%13.25M
Total non current liabilities
-4.08%208.08M
3.38%211.76M
-5.73%195.01M
-4.40%199.07M
-5.99%216.94M
-7.04%204.83M
-4.96%206.87M
3.86%208.24M
17.54%230.76M
12.75%220.35M
Total liabilities
8.58%1.01B
-0.91%975.47M
-7.70%877.36M
-4.77%972.52M
18.14%934.59M
63.44%984.44M
50.48%950.58M
48.87%1.02B
17.51%791.12M
-20.45%602.32M
Shareholders equity
Paid-in capital
6.26%601.07M
6.28%601.2M
5.04%594.16M
5.04%594.16M
0.73%565.65M
0.73%565.65M
0.73%565.65M
0.73%565.65M
0.00%561.54M
0.00%561.54M
Capital reserve funds
36.57%3.55B
35.97%3.52B
30.31%3.35B
30.74%3.35B
4.35%2.6B
4.00%2.59B
3.75%2.57B
3.51%2.56B
0.74%2.49B
0.53%2.49B
Surplus reserve funds
3.09%300.53M
1.90%297.08M
1.90%297.08M
1.90%297.08M
0.00%291.53M
0.00%291.53M
0.00%291.53M
0.00%291.53M
0.00%291.53M
0.00%291.53M
Retained profit
6.95%6.95B
5.95%6.75B
6.07%6.66B
5.37%6.57B
3.85%6.5B
-1.66%6.37B
-9.66%6.28B
-8.89%6.23B
-0.01%6.26B
12.39%6.48B
Less:Treasury stock
181.44%200.85M
163.56%188.09M
0.00%71.36M
0.00%71.36M
--71.36M
--71.36M
--71.36M
--71.36M
----
----
Other composite income
-31.53%2.95M
-29.67%3.68M
59.82%3.71M
10.90%3.82M
-16.03%4.31M
823.06%5.23M
161.74%2.32M
200.06%3.44M
245.92%5.13M
115.11%566.78K
Shareholders equity without minority interests
13.31%11.21B
12.64%10.98B
12.41%10.84B
12.07%10.74B
2.93%9.89B
-0.72%9.74B
-6.22%9.65B
-5.72%9.59B
0.27%9.61B
8.05%9.82B
Minority interests
----
100.22%358.55
100.22%360.25
100.25%404.72
-0.02%-162.55K
-0.02%-162.55K
-0.01%-162.56K
-0.01%-162.52K
-0.01%-162.52K
-0.01%-162.53K
Total shareholder equity
13.31%11.21B
12.65%10.98B
12.41%10.84B
12.07%10.74B
2.93%9.89B
-0.72%9.74B
-6.22%9.65B
-5.72%9.59B
0.27%9.61B
8.05%9.82B
Total liabilityies and equity
12.90%12.22B
11.40%11.95B
10.61%11.72B
10.45%11.72B
4.08%10.83B
2.99%10.73B
-2.94%10.6B
-2.27%10.61B
1.40%10.4B
5.86%10.42B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 67.20%3.5B0.45%3.08B-6.96%2.55B-15.49%2.44B-29.29%2.09B-6.41%3.06B-19.08%2.74B-12.57%2.89B-4.51%2.96B8.62%3.27B
Transactional financial assets -24.59%1.57B16.85%1.79B42.36%2.35B47.34%2.41B14.33%2.08B4.64%1.53B5.93%1.65B0.72%1.64B51.03%1.82B33.50%1.47B
Notes receivable and accounts receivable -34.48%260.95M33.94%371.01M30.78%269.6M117.72%383.74M210.63%398.29M1.61%277M-72.23%206.15M-81.13%176.25M-80.95%128.22M-59.54%272.62M
-Accounts receivable -34.48%260.95M33.94%371.01M30.78%269.6M117.72%383.74M210.63%398.29M1.61%277M-72.23%206.15M-81.13%176.25M-80.95%128.22M-59.54%272.62M
Other receivables (including interest and dividends) 5.40%4.07M-29.47%14.86M-10.44%3.6M-40.70%3.49M-22.03%3.86M-63.58%21.07M-44.45%4.02M-9.23%5.89M-38.25%4.95M942.25%57.84M
-Dividend receivable -----40.19%10.38M-------------67.29%17.36M--------------53.08M
-Other receivable ----20.80%4.47M-------------22.22%3.7M-----9.23%5.89M-----14.19%4.76M
Advance payment 79.14%65.04M81.73%77.37M20.62%59.37M-10.87%40.98M-24.39%36.31M-13.40%42.58M-13.09%49.22M-25.98%45.98M-50.02%48.02M-27.42%49.16M
Inventories 19.72%1.03B26.80%950.34M35.34%932.04M32.66%860.51M28.53%858.85M2.28%749.46M-5.96%688.68M-0.41%648.65M16.10%668.23M26.75%732.72M
Receivable financing -41.68%10.44M-44.74%6.31M-37.02%18.56M-87.72%1.63M542.30%17.9M121.51%11.42M3,040.73%29.47M1,474.78%13.32M-93.89%2.79M-63.70%5.16M
Non-current assets due within one year -------------------------27.84%201.33M-27.16%201.36M-26.47%201.34M90.91%312.8M
Other current assets 2,591.34%52.86M189.96%41.69M-39.83%31.88M-30.59%32.26M-77.45%1.96M-35.66%14.38M484.55%52.99M388.57%46.48M-97.77%8.71M-94.27%22.35M
Total current assets 18.23%6.49B10.82%6.33B10.50%6.22B9.03%6.18B-6.03%5.49B-7.73%5.71B-16.98%5.62B-17.56%5.66B-8.26%5.84B3.12%6.19B
Non Current assets
Debt investment 63.25%493.28M--409.66M--307.12M--304.66M--302.17M--------------------
Other non-current financial assets 0.00%30M0.00%30M0.00%30M0.00%30M0.00%30M0.00%30M0.00%30M0.00%30M--30M--30M
Fixed assets ----29.80%2.34B------------9.53%1.8B-----3.39%1.65B-----2.48%1.65B
Constru in process -----19.96%1.51B------------64.02%1.89B----129.25%2B----44.41%1.15B
Construction materials -----1.73%2.28M-------------0.53%2.32M-----0.30%2.33M-----0.50%2.33M
Intangible assets -2.60%273.22M-2.82%275.36M-5.27%271.28M-5.25%278.08M-4.42%280.51M-1.61%283.35M-1.13%286.38M-0.85%293.48M10.32%293.47M16.09%287.99M
Development expenditure 4.56%831.88M4.39%823.38M7.26%818.63M10.99%813.11M12.19%795.57M21.06%788.78M22.36%763.2M27.07%732.56M33.00%709.16M20.04%651.58M
Long deferred expense -19.02%7.54M-18.15%7.98M-17.30%8.43M-16.60%8.87M-15.94%9.31M-15.23%9.76M-14.65%10.19M-14.10%10.63M-10.86%11.08M-10.19%11.51M
Deferred tax assets 50.81%165.06M37.50%157.01M17.25%152.24M22.21%168.95M94.40%109.45M177.11%114.19M237.57%129.84M348.83%138.25M113.99%56.3M52.03%41.21M
Usufruct assets -50.10%4.57M-54.17%4.56M-58.73%4.48M-45.43%6.59M-31.23%9.16M-29.76%9.95M-27.81%10.84M-25.28%12.08M4.58%13.32M4.01%14.17M
Other non current assets -39.16%56.6M-33.18%54.2M-55.34%37M-34.67%49.99M-77.30%93.03M-79.02%81.12M-73.21%82.84M-68.16%76.51M49.75%409.8M98.16%386.6M
Total non current assets 7.43%5.73B12.07%5.62B10.73%5.5B12.07%5.54B17.03%5.34B18.68%5.02B20.01%4.97B24.11%4.94B17.21%4.56B10.14%4.23B
Total assets 12.90%12.22B11.40%11.95B10.61%11.72B10.45%11.72B4.08%10.83B2.99%10.73B-2.94%10.6B-2.27%10.61B1.40%10.4B5.86%10.42B
Liabilities
Current liabilities
Notes payable and accounts payable 23.73%111.04M-1.57%96.32M24.20%107.43M136.15%105.54M54.32%89.74M94.58%97.86M155.94%86.5M18.42%44.69M91.62%58.16M48.33%50.29M
-Accounts payable 23.73%111.04M-1.57%96.32M24.20%107.43M136.15%105.54M54.32%89.74M94.58%97.86M155.94%86.5M18.42%44.69M91.62%58.16M48.33%50.29M
Contract liabilities 9.79%52.26M-47.03%30.87M-40.91%32.64M-22.21%52.99M-58.20%47.6M30.19%58.27M74.70%55.24M86.32%68.13M115.49%113.87M-21.94%44.76M
Advance receipts --------------------------251.99K--603.56K--1.1M----
Salaries payable 17.91%167.51M-17.79%127.51M-1.78%151.94M-1.59%139.76M-10.14%142.07M37.41%155.1M10.61%154.69M4.51%142.02M26.72%158.11M-8.70%112.87M
Taxs payable -14.88%18.81M-5.57%14.66M-19.31%10.21M17.33%16.91M62.02%22.1M-12.94%15.53M-79.24%12.65M-88.89%14.41M-63.47%13.64M-61.97%17.83M
Other payable (including interest and dividends) 13.34%454.18M11.81%491.61M-11.18%377.54M-15.09%454.01M92.96%400.71M195.59%439.67M201.19%425.06M288.63%534.68M-8.77%207.66M-49.60%148.74M
-Dividend payable --1.97M--18.83M--------------------------------
-Other payable ----7.53%472.78M------------195.59%439.67M----288.63%534.68M-----33.13%148.74M
Non current liabilities due within one year -84.54%2.36M-81.71%2.37M-74.42%2.29M-47.66%3.96M111.73%15.28M77.58%12.96M36.24%8.96M-4.91%7.56M97.25%7.21M71.63%7.3M
Other current liabilities 227.01%517.84K59.33%368.71K-17.55%297.87K-70.56%275.58K-74.01%158.36K37.90%231.41K149.90%361.26K713.09%936.18K87.63%609.35K-70.75%167.81K
Total current liabilities 12.40%806.67M-2.04%763.71M-8.25%682.35M-4.87%773.45M28.07%717.66M104.10%779.61M79.62%743.71M67.45%813.04M17.50%560.36M-32.00%381.97M
Current liabilities
Long term account payable ----21.19%13.65M------------4.91%11.27M----20.34%12.27M----652.77%10.74M
Deferred tax liabilities 91.01%21.86M--19.3M---------34.97%11.45M-------------53.77%17.6M-8.24%31.11M
Long term deferred income -6.33%171.13M-5.41%175.02M-5.37%177.32M-4.27%179.63M-3.63%182.7M11.97%185.04M11.99%187.38M32.16%187.63M32.15%189.58M13.53%165.25M
Lease liabilities -55.10%3.67M-55.64%3.78M-51.54%3.91M-34.58%5.45M-39.06%8.18M-35.64%8.53M-38.16%8.07M-31.55%8.33M-2.45%13.42M-8.93%13.25M
Total non current liabilities -4.08%208.08M3.38%211.76M-5.73%195.01M-4.40%199.07M-5.99%216.94M-7.04%204.83M-4.96%206.87M3.86%208.24M17.54%230.76M12.75%220.35M
Total liabilities 8.58%1.01B-0.91%975.47M-7.70%877.36M-4.77%972.52M18.14%934.59M63.44%984.44M50.48%950.58M48.87%1.02B17.51%791.12M-20.45%602.32M
Shareholders equity
Paid-in capital 6.26%601.07M6.28%601.2M5.04%594.16M5.04%594.16M0.73%565.65M0.73%565.65M0.73%565.65M0.73%565.65M0.00%561.54M0.00%561.54M
Capital reserve funds 36.57%3.55B35.97%3.52B30.31%3.35B30.74%3.35B4.35%2.6B4.00%2.59B3.75%2.57B3.51%2.56B0.74%2.49B0.53%2.49B
Surplus reserve funds 3.09%300.53M1.90%297.08M1.90%297.08M1.90%297.08M0.00%291.53M0.00%291.53M0.00%291.53M0.00%291.53M0.00%291.53M0.00%291.53M
Retained profit 6.95%6.95B5.95%6.75B6.07%6.66B5.37%6.57B3.85%6.5B-1.66%6.37B-9.66%6.28B-8.89%6.23B-0.01%6.26B12.39%6.48B
Less:Treasury stock 181.44%200.85M163.56%188.09M0.00%71.36M0.00%71.36M--71.36M--71.36M--71.36M--71.36M--------
Other composite income -31.53%2.95M-29.67%3.68M59.82%3.71M10.90%3.82M-16.03%4.31M823.06%5.23M161.74%2.32M200.06%3.44M245.92%5.13M115.11%566.78K
Shareholders equity without minority interests 13.31%11.21B12.64%10.98B12.41%10.84B12.07%10.74B2.93%9.89B-0.72%9.74B-6.22%9.65B-5.72%9.59B0.27%9.61B8.05%9.82B
Minority interests ----100.22%358.55100.22%360.25100.25%404.72-0.02%-162.55K-0.02%-162.55K-0.01%-162.56K-0.01%-162.52K-0.01%-162.52K-0.01%-162.53K
Total shareholder equity 13.31%11.21B12.65%10.98B12.41%10.84B12.07%10.74B2.93%9.89B-0.72%9.74B-6.22%9.65B-5.72%9.59B0.27%9.61B8.05%9.82B
Total liabilityies and equity 12.90%12.22B11.40%11.95B10.61%11.72B10.45%11.72B4.08%10.83B2.99%10.73B-2.94%10.6B-2.27%10.61B1.40%10.4B5.86%10.42B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Dahua Certified Public Accountants (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Medical Device Concept
Medical Device Concept
Intraday+0.57%